PacBio appoints Jim Gibson as CFO, effective March 31, 2025

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Jim Gibson appointed CFO effective March 31, 2025; Christian Henry ceases as interim CFO.
Gibson previously CFO at Sequoia and Willow Innovations; held exec roles at GoDaddy, Tesla, Apple, Netflix.
Compensation: $500k base salary, 55% target bonus, 2M stock options, 1M RSUs with standard vesting.
Severance provides 12 months salary and COBRA; change-in-control triggers full equity acceleration.
PacBio targets positive cash flows by end of 2027, per press release announcing Gibson's hiring.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jim R. Gibson

Chief Financial Officer

PACB · PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Effective: 2025-03-31
Filed: March 27, 2025, 7:59 PM ET

On March 24, 2025, Pacific Biosciences of California, Inc. (the “Company”) entered into an offer letter with Jim R. Gibson to serve as its Chief Financial Officer. Mr. Gibson will be appointed as the Company’s Chief Financial Officer and principal financial officer effective as of as his first date of employment, which is anticipated to be March 31, 2025

Role change

Christian Henry

President and Chief Executive Officer

PACB · PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Effective: 2025-03-31
Successor: Jim R. Gibson
Filed: March 27, 2025, 7:59 PM ET

Christian Henry, the Company’s President and Chief Executive Officer, who has been serving also as the Company’s interim Chief Financial Officer and principal financial officer since December 6, 2024 will cease serving as interim Chief Financial Officer and principal financial officer upon commencement of Mr. Gibson’s employment but will continue serving as the Company’s President and Chief Executive officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jim R. Gibson was appointed as Chief Financial Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 24, 2025, Pacific Biosciences of California, Inc. (the “Company”) entered into an offer letter with Jim R. Gibson to serve as its Chief Financial Officer. Mr. Gibson will be appointed as the Company’s Chief Financial Officer and principal financial officer effective as of as his first date of employment, which is anticipated to be March 31, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christian Henry changed role as President and Chief Executive Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Action: ceases serving as interim CFO
Role: President and Chief Executive Officer

Exact text from the filing

Christian Henry, the Company’s President and Chief Executive Officer, who has been serving also as the Company’s interim Chief Financial Officer and principal financial officer since December 6, 2024 will cease serving as interim Chief Financial Officer and principal financial officer upon commencement of Mr. Gibson’s employment but will continue serving as the Company’s President and Chief Executive officer.

View on SEC.gov

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filing history →

Source: SEC EDGAR

accession 0001299130-25-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.